Poland· PL-100094179
Pluscard
A acetylsalicylic acid product containing acidum acetylsalicylicum + glycinum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Acetylsalicylic acid is registered in 14 of 19 countries.
Countries holding a registration under ATC B01AC06 (acetylsalicylic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Acetylsalicylic acid · ATC B01AC06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum acetylsalicylicum + Glycinum
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B01AC06
- ATC class
- Acetylsalicylic acid
- Defined daily dose
- 1 Tablette, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990487011
- gtin05909990487028
- gtin05906071009858
- gtin05906071009865
- gtin05906071009872
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
836 interactions on record for acetylsalicylic acid.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acetylsalicylic acid · interactions on record
836 records
- 55 severe
- 246 moderate
- 39 minor
- 429 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acetylsalicylic acid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Czechia · Godasal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/81d9a05f-aaff-4684-94f3-fddf1e8d149b GET /v1/drugs/81d9a05f-aaff-4684-94f3-fddf1e8d149b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "100 mg + 40 mg",
"packaging": "05909990487011 ¦ OTC ¦ 15573\n20 tabl.\n05909990487028 ¦ OTC ¦ 15574\n40 tabl.\n05906071009872 ¦ OTC ¦ 125147\n15 tabl.\n05906071009858 ¦ OTC ¦ 125148\n30 tabl.\n05906071009865 ¦ OTC ¦ 125149\n60 tabl.",
"substance": "Acidum acetylsalicylicum 100 mg + Glycinum 40 mg",
"common_name": "Acidum acetylsalicylicum + Glycinum",
"pl_product_id": "100094179",
"pozwolenie_nr": "04870",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about acetylsalicylic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.